Role of E3 Ubiquitin ligase RNF133 in T cell function and tolerance
E3 泛素连接酶 RNF133 在 T 细胞功能和耐受性中的作用
基本信息
- 批准号:10311074
- 负责人:
- 金额:$ 40万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-01-01 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAgeAge-MonthsAntibodiesAntigensAutoimmuneAutoimmune DiseasesAutoimmunityB-LymphocytesCD4 Positive T LymphocytesCell physiologyCellsDevelopmentDiseaseEnsureExhibitsExperimental Autoimmune EncephalomyelitisGenerationsGenesGeneticGoalsHelper-Inducer T-LymphocyteHomologous GeneIgG1Immune ToleranceImmunoglobulin GIn VitroInflammationInflammatoryInterleukinsInvadedKnock-outKnockout MiceKnowledgeLeadLymphocyte ActivationLymphoid TissueMaintenanceMediatingMethodsModelingMolecularPathogenicityPeptidesPeripheralPharmacologyPhasePhenotypePhysiologicalPreventionProductionPropertyProtein Array AnalysisProteinsReagentRegulationRegulatory T-LymphocyteResearchRoleSelf ToleranceSignal TransductionSymptomsT-LymphocyteTestingTherapeuticTimeTissuesTumor stageWorkYeastsadaptive immune responsebasecytokineearly onsetin vivoinsightknock-downoral tolerancepathogenperipheral tolerancepreventprogramsresponsescreeningubiquitin-protein ligaseyeast two hybrid system
项目摘要
PROJECT SUMMARY/ABSTRACT
CD4+ T cells are the master regulators of adaptive immune responses, and a breakdown of self-tolerance in
CD4+ cells leads to many autoimmune diseases. Understanding of the mechanisms underlying T cell tolerance
will provide new significant insight in advancing our knowledge on the signaling and genetic controls of T
helper (TH) cell tolerance programs that may have therapeutic implications for inflammatory diseases.
Recently, we have acknowledged the essential role of GRAIL in immunological tolerance. Despite the
critical role of GRAIL in T cell tolerance, GRAIL knockout (KO) mice do not spontaneously develop
autoimmunity at early age, suggesting that closely-related protein(s) to GRAIL could contribute to control of
the early onset of inflammation. Interestingly, among the five GRAIL homologs, RNF133 shows the highest
expression in tolerant T cells, suggesting that RNF133 along with GRAIL could contribute to establishment of T
cell tolerance; however its role in T cells has not been studied. RNF133 KO CD4+ T cells activated in vitro and
in vivo under tolerogenic conditions exhibited enhanced level of proliferation and cytokine (interleukin (IL)-17
and IL-21) production compared to wild-type (WT) T cells, indicating the potential role of RNF133 in controlling
TH (TH17 and T follicular (Tfh)) cell responses. In fact, RNF133 KO mice have elevated levels of IgG and IgG1
in the sera and percentage of TH17 and Tfh cells in the peripheral lymphoid tissues as early as 12 weeks of
age followed by rise of autoimmune symptoms at 5-6 months of age. Moreover, RNF133 expression in
regulatory T cells (Tregs) is essential to maintain their suppressive function, as well as stability and prevents
them from acquiring pathogenic TH17 phenotype, suggesting that RNF133 functions to control pathogenic TH
cell responses. Based on this, we hypothesize that RNF133 may be an important checkpoint molecule in
maintaining immunological tolerance and in preventing the onset and development of inflammation.
In Aim 1, we propose to determine the molecular mechanisms responsible for regulation and function of
RNF133 in T cell tolerance by utilizing conditional gene knockdown approaches and in vivo T cell tolerance
models. In Aim 2, we will determine the role of RNF133 in Tfh cell tolerance and underlying mechanisms as
well. In addition, we will assess the mechanisms whereby RNF133 controls antibody-mediated autoimmunity.
In Aim 3, we will determine the mechanism(s) by which RNF133 regulates Tregs and TH17 cell
programming and stability. The physiological significance of this finding will be assessed in an experimental
allergic encephalomyelitis (EAE) model. We will employ yeast two-hybrid screening and reverse phase protein
array assay to identify the exact target(s) of RNF133, which determines its function in TH programming.
The proposed research will provide new significant insight into characterization of mechanisms
underlying T cell tolerance that will lead to development of pharmacological approaches to promote
the tolerance state in terms of autoimmunity.
项目摘要/摘要
CD4+ T细胞是自适应免疫反应的主要调节剂,并且是自我耐受性的分解
CD4+细胞导致许多自身免疫性疾病。了解T细胞耐受性的机制
将提供新的重要见解,以促进我们对T的信号传导和遗传控制的了解
助手(TH)细胞耐受性程序可能对炎症性疾病具有治疗意义。
最近,我们认识到圣杯在免疫耐受性中的重要作用。尽管有
Grail在T细胞耐受性,Grail敲除(KO)小鼠中的关键作用不会自发发展
在幼年时期的自身免疫性,表明与圣杯密切相关的蛋白质可能有助于控制
炎症的早期发作。有趣的是,在这五个Grail同源物中,RNF133显示出最高的
耐受性T细胞中的表达,表明RNF133与圣杯一起可能有助于建立T
细胞耐受性;但是,尚未研究其在T细胞中的作用。 RNF133 KO CD4+ T细胞在体外激活,并且
在耐受性条件下体内表现出增殖水平增强和细胞因子(白介素(IL)-17)
与野生型(WT)T细胞相比,IL-21)产生的产生,表明RNF133在控制中的潜在作用
Th(Th17和T卵泡(TFH))细胞反应。实际上,RNF133 KO小鼠的IgG和IgG1水平升高
在周围淋巴组织中Th17和TFH细胞的血清和百分比中
年龄在5-6个月大时出现自身免疫性症状的升高。此外,RNF133在
调节性T细胞(Tregs)对于维持其抑制功能以及稳定性至关重要
它们是从获取致病性Th17表型中的,这表明RNF133功能控制致病
细胞反应。基于此,我们假设RNF133可能是重要的检查点分子
保持免疫学耐受性并防止炎症的发作和发展。
在AIM 1中,我们建议确定负责调节和功能的分子机制
通过使用条件基因敲低方法和体内T细胞耐受性,T细胞耐受性的RNF133
型号。在AIM 2中,我们将确定RNF133在TFH细胞耐受性和潜在机制中的作用
出色地。此外,我们将评估RNF133控制抗体介导的自身免疫性的机制。
在AIM 3中,我们将确定RNF133调节Treg和Th17细胞的机制
编程和稳定性。该发现的生理意义将在实验中评估
过敏性脑脊髓炎(EAE)模型。我们将采用酵母双杂交筛选和反向相蛋白
数组测定以识别RNF133的确切目标,该目标确定其在TH编程中的功能。
拟议的研究将为机制的表征提供新的重要洞察力
潜在的T细胞耐受性将导致促进药理方法的发展
自身免疫性方面的公差状态。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Distinct Immunophenotypes of T Cells in Bronchoalveolar Lavage Fluid From Leukemia Patients With Immune Checkpoint Inhibitors-Related Pulmonary Complications.
- DOI:10.3389/fimmu.2020.590494
- 发表时间:2020
- 期刊:
- 影响因子:7.3
- 作者:Kim ST;Sheshadri A;Shannon V;Kontoyiannis DP;Kantarjian H;Garcia-Manero G;Ravandi F;Im JS;Boddu P;Bashoura L;Balachandran DD;Evans SE;Faiz S;Ruiz Vazquez W;Divenko M;Mathur R;Tippen SP;Gumbs C;Neelapu SS;Naing A;Wang L;Diab A;Futreal A;Nurieva R;Daver N
- 通讯作者:Daver N
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Roza Insafetdinovna Nurieva其他文献
Roza Insafetdinovna Nurieva的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Roza Insafetdinovna Nurieva', 18)}}的其他基金
Mechanism-rooted therapeutic strategies for immune-related toxicities induced by checkpoint inhibitors
检查点抑制剂引起的免疫相关毒性的基于机制的治疗策略
- 批准号:
10753628 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
Role of Cul4A in Governing Th2-Type Tolerance
Cul4A 在控制 Th2 型耐受中的作用
- 批准号:
10198025 - 财政年份:2018
- 资助金额:
$ 40万 - 项目类别:
Role of Cul4A in Governing Th2-Type Tolerance
Cul4A 在控制 Th2 型耐受中的作用
- 批准号:
9770641 - 财政年份:2018
- 资助金额:
$ 40万 - 项目类别:
Grail-targeting breaks the immune tolerance to melanoma
圣杯靶向打破了对黑色素瘤的免疫耐受
- 批准号:
9379209 - 财政年份:2017
- 资助金额:
$ 40万 - 项目类别:
STAT1: New regulator of inflammatory Th17 and Th2 cells
STAT1:炎症 Th17 和 Th2 细胞的新调节因子
- 批准号:
9112386 - 财政年份:2016
- 资助金额:
$ 40万 - 项目类别:
STAT1: New regulator of inflammatory Th17 and Th2 cells
STAT1:炎症 Th17 和 Th2 细胞的新调节因子
- 批准号:
9206467 - 财政年份:2016
- 资助金额:
$ 40万 - 项目类别:
Role of Grail in maintaining humoral immune tolerance
Grail 在维持体液免疫耐受中的作用
- 批准号:
9089880 - 财政年份:2015
- 资助金额:
$ 40万 - 项目类别:
Regulation of T cell activation and tolerance by Grail
Grail 对 T 细胞活化和耐受的调节
- 批准号:
8468985 - 财政年份:2009
- 资助金额:
$ 40万 - 项目类别:
Regulation of T cell activation and tolerance by Grail
Grail 对 T 细胞活化和耐受的调节
- 批准号:
7869435 - 财政年份:2009
- 资助金额:
$ 40万 - 项目类别:
Regulation of T cell activation and tolerance by Grail
Grail 对 T 细胞活化和耐受的调节
- 批准号:
7700519 - 财政年份:2009
- 资助金额:
$ 40万 - 项目类别:
相似国自然基金
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CHCHD2在年龄相关肝脏胆固醇代谢紊乱中的作用及机制
- 批准号:82300679
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
颗粒细胞棕榈酰化蛋白FXR1靶向CX43mRNA在年龄相关卵母细胞质量下降中的机制研究
- 批准号:82301784
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Engineered tissue arrays to streamline deimmunized DMD gene therapy vectors
工程组织阵列可简化去免疫 DMD 基因治疗载体
- 批准号:
10724882 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
Hypothalamic Sleep-Wake Neuron Defects in Alzheimer’s disease
阿尔茨海默病中的下丘脑睡眠-觉醒神经元缺陷
- 批准号:
10770001 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
Preservation of brain NAD+ as a novel non-amyloid based therapeutic strategy for Alzheimer’s disease
保留大脑 NAD 作为阿尔茨海默病的一种新型非淀粉样蛋白治疗策略
- 批准号:
10588414 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
Latent profiles of prenatal exposure to toxic metals and psychosocial risk and protective factors: testing associations with child developmental outcomes and moderations by caregiving experience
产前接触有毒金属和心理社会风险和保护因素的潜在特征:测试与儿童发育结果的关联以及护理经验的调节
- 批准号:
10606183 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
The Role of Viral Exposure and Age in Alzheimer's Disease Progression
病毒暴露和年龄在阿尔茨海默病进展中的作用
- 批准号:
10717223 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别: